Speakers

Expand/Collapse

Souvik Biswas
Director, Discovery
Verve Therapeutics

Yogev Debbi
Co-Founder & CEO
Mana.bio

Yogev Debbi is a Co-founder and CEO of Mana.bio. Mana.bio is an AI based drug delivery startup, leveraging machine learning and AI in order to identify formulations of lipid nanoparticles drug delivery systems. Prior to that, Yogev was a Co-founder and COO of Genome Compiler, a leading gene editing platform that was acquired by Twist Bioscience, a global leader in synthetic biology. Following the acquisition, Yogev was the General Manager of the Israel R&D center and took part of Twist IPO. Yogev is very excited about the integration of software and machine learning with biology and is eager to leverage the integration of these two fields in order to bring disruptive products for improving health and quality of life.

Day One

Wednesday July 20, 2022

8:50 am | Opening Remarks

David Cipolla
VP of Research
Insmed

Day One

Wednesday July 20, 2022

3:15 pm | Formulation & Delivery Challenges with Inhaled Lipid Nanoparticle Formulations

Vincent Nebot
Chief Technical Officer
Polypeptide Therapeutic Solutions (PTS)

Day One

Wednesday July 20, 2022

11:30 am | Polymer Lipid Hybrids: A Chemical Toolbox for LNP Formulations

Bryant Nelson
Staff Research Chemist
National Institute of Standards & Technology

Dr. Shan Zou
Senior Research Officer, Team Leader for Nanoscale Measurement Disciplines; Adjunct Professor of Chemistry
Metrology Research Centre of the National Research Council Canada (NRC); Carleton University

Anitha Thomas
Director, Delivery
Precision Nanosystems

Day One

Wednesday July 20, 2022

12:10 pm | Novel Ionizable Lipid Library for Enabling Non-Viral Delivery

1:30 pm | Panel Discussion: Delivering Novel Treatments through Lipid-Based NPs Beyond Liver

Priya Karmali
Chief Technology Officer
Capstan Therapeutics

Day One

Wednesday July 20, 2022

4:45 pm | Closing Remarks & End of Day One

9:10 am | Developing Targeted Lipid Nanoparticles (tLNPs) to Enable Off-the-Shelf Immunotherapies

8:50 am | Opening Remarks

John Lewis
Founder & Chief Executive Officer
Entos Pharmaceuticals

Day Two

Thursday 21 July 2022

10:00 am | Fireside Chat

9:00 am | Exploring a Next-Gen Delivery Platform for Targeted Delivery: Fusogenix Proteo-Lipid Vehicle (PLV)

Chun-Wan Yen
Principal Scientist
Genentech

Day Two

Thursday 21 July 2022

2:00 pm | Predictive High-Throughput Screening of Oligonucleotide Lipid Nanoparticles

Cory Sago
Senior Director & Head of LNP Discovery
Beam Therapeutics

Day One

Wednesday July 20, 2022

1:30 pm | Panel Discussion: Delivering Novel Treatments through Lipid-Based NPs Beyond Liver

Day Two

Thursday 21 July 2022

10:00 am | Fireside Chat

9:30 am | Multiplexed Screening of LNPs in Vivo Enabled by Nucleic Acid Barcoding

Dominik Witzigmann
Co-Founder & Chief Executive Officer
Nanovation Therapeutics

Day One

Wednesday July 20, 2022

4:45 pm | Closing Remarks & End of Day One

11:40 am | Next-Generation Lipid Nanoparticle Technologies Enabling (Extra) Hepatic Nucleic Acid Delivery

Hemant Kumar
Chief Technology & Manufacturing Officer
Genprex

Hila Epstein-Barash
Chief Technology Officer & Co-Founder
Potentia Therapeutics

Day One

Wednesday July 20, 2022

1:30 pm | Panel Discussion: Delivering Novel Treatments through Lipid-Based NPs Beyond Liver

James Ferguson
Chief Medical Officer
Matinas BioPharma

Day One

Wednesday July 20, 2022

9:40 am | Expanding Current Capabilities for Intracellular Drug Delivery with a Lipid Nano-Crystal (LNC) Platform

Day Two

Thursday 21 July 2022

2:15 pm | Chair’s Closing Remarks & End of Summit

10:00 am | Fireside Chat

8:50 am | Chair’s Opening Remarks

Kalina Paunovska
Postdoctoral Scholar Dahlman Lab
Georgia Institute of Technology

Day One

Wednesday July 20, 2022

2:15 pm | Using High-Throughput LNP Screening to Identify Novel Non-Liver Delivery Vehicles

Ruchi Shah
Associate Director, New Therapeutic Modalities
Eli Lily

Day Two

Thursday 21 July 2022

11:30 am | Roundtable Discussion: Improving Cross-Functional Collaboration

Kristina Friis
Senior Scientist, Advanced Drug Delivery
AstraZeneca

Day One

Wednesday July 20, 2022

4:15 pm | Spray Drying of Lipid Nanoparticles Enables Intratracheal Delivery

Sonya Zabludoff
Vice President, Clinical Development
Nitto BioPharma

Day One

Wednesday July 20, 2022

3:45 pm | Roundtable: Elevating Patient Centric Administration

Day Two

Thursday 21 July 2022

1:30 pm | Elevating Clinical Design for a Lipid Nanoparticle Candidate

Manuel Sanchez-Felix
Senior Fellow, Novel Delivery Technologies
Novartis

Day Two

Thursday 21 July 2022

11:30 am | Roundtable Discussion: Improving Cross-Functional Collaboration

Qiaobing Xu
Founder & Chief Executive Officer
Hopewell Therapeutics

Rajesh Shinde
Senior Director of Manufacturing & Technology Operations
Genprex

Xiuling Lu
Associate Professor
University of Connecticut